Our People

To assess and advocate for responsible, favorable, and clear global regulations that impact clinical translation, cell manufacturing, and commercialization.

Co-Chair - Melissa K. Carpenter, PhD
Carpenter Consulting Corporation, USA

Co-Chair - Tenneille E. Ludwig, PhD
WiCell, USA

Ricardo Baptista, PhD
SmartCella, Sweden

Ivana Barbaric, DPhil
University of Sheffield, UK

Jacqueline Barry, PhD
Cell and Gene Therapy Catapult, UK

Alessandro Bertero , PhD
Università di Torino, Italy

Kapil Bharti, PhD
National Institutes of Health (NIH), USA

Andrew Gaffney, PhD
STEMCELL Technologies Inc., Canada

Derek J. Hei, PhD
Kenai Therapeutics, USA

Zoe Hewitt, PhD
Regenerative Cell Therapy Consulting Limited, UK

Deborah Hursh, PhD
Hursh Cell Therapy Consulting, LLC, USA

Uma Lakshmipathy, PhD
Thermo Fisher Scientific, USA

Jane S. Lebkowski, PhD
Regenerative Patch Technologies, USA

Marinna Madrid, PhD
Cellino Biotech, USA

Jennifer Moody, PhD
Danaher Corporation, Canada

Charles Murry, MD, PhD
USC Stem Cell, USA

Yoji Sato, PhD
National Institute of Health Sciences, Japan

Jihwan Song, DPhil
CHA University, South Korea

Yoshie Tsurumaki, Rph
Healios, Japan

Debra Webster, PhD
SSI Strategy, USA

To foster a global ISSCR community, advise on membership policies, select travel awards, and recommend guidelines for encouraging EDI across the society.

Chair - Ole Pless, PhD, MSc
Fraunhofer ITMP, Germany

Vice Chair - Athanasia D. Panopoulos, PhD
Cedars-Sinai Medical Center, USA

Nissim Benvenisty, MD, PhD
Hebrew University, Israel

Andrea Ditadi, PhD
Ospedale San Raffaele, Italy

Mubeen Goolam, PhD
University of Cape Town, South Africa

Akitsu Hotta, PhD
Kyoto University, Japan

Lijian Hui, PhD
Shanghai Institute of Biochemistry and Cell Biology (SIBCB), China

Madeline A. Lancaster, PhD
Medical Research Council (MRC), UK

Rebecca Matsas, PhD
Hellenic Pasteur Institute, Greece

Verónica Alejandra Palma, PhD
Universidad de Chile, Chile

Lygia da Veiga Pereira, PhD
University of São Paulo, Brazil

Eugenia Piddini, PhD, BSc, MSc
University of Bristol, UK

Nika Shakiba, PhD
University of British Columbia, Canada

Jihwan Song, DPhil
CHA University, South Korea

Shahragim Tajbakhsh, PhD
Institut Pasteur Stem Cells and Development, France

Su-Yi Tsai, PhD
National Taiwan University, Taiwan

Responsible for reviewing candidates for the Board of Directors and presenting an election slate for annual elections.

Chair -Shuibing Chen, PhD
Weill Cornell Medicine, USA 

Chair -Valentina Greco, PhD
Yale School of Medicine, Genetics Department & Yale Stem Cell Center, USA  

Kelvin K. Hui, PhD
Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan

Rosario Isasi, JD MPH
University of Miami, USA

Therése Kallur, PhD    
Biolamina AB, Sweden, USA

Bhavana Muralidharan, PhD   
Institute for Stem Cell Science and Regenerative Medicine (inStem), India

Catherine Priest, PhD
Neurona Therapeutics, USA

Lorenz Studer, MD
Memorial Sloan Kettering Cancer Center, USA

Christine Wells, PhD
University of Melbourne, Australia

Wei Xie, PhD
Tsinghua University, China

The Public Policy Committee seeks to achieve public policies that regulate stem cell research and translation in effective and appropriate ways worldwide.

Chair - Sean J. Morrison, PhD
Children's Medical Research Institute at UT Southwestern, USA

Eric Anthony
University of California, San Francisco (UCSF), USA

R. Alta Charo, JD
University of Wisconsin, USA

George Q. Daley, MD, PhD
Harvard Medical School, USA

Lawrence S.B. Goldstein, PhD
University of California San Diego, USA

Kazuto Kato, PhDOsaka University Medical School, Japan

Robin Lovell-Badge, PhD, FRS
The Francis Crick Institute, UK

Zubin Master, BSc, PhD
Wake Forest University School of Medicine, USA

Sarah E. Millar, PhD
Icahn School of Medicine at Mount Sinai, USA

Megan Munsie, PhD
Murdoch Children’s Research Institute & University of Melbourne, Australia

Malin Parmar, PhD
Lund University, Sweden

Yaojin Peng, PhD
Chinese Academy of Sciences, China

Douglas Sipp
RIKEN Center for Biosystems Dynamics, Japan

Jeremy Sugarman, MD, MPH, MA
Johns Hopkins University, USA

Giuseppe Testa, MD PhD MA
Foundation Human Technopole, Italy

Alan O. Trounson, MSc PhD
Monash University, Australia

Fiona Watt, PhD
European Molecular Biology Laboratory (EMBL) Heidelberg, Germany

Magdalena Zernicka-Goetz, PhD
California Institute of Technology, USA

Ex Officio - Mubeen Goolam, PhDUniversity of Cape Town, South Africa

Ex Officio - Lizhong Liu, PhDWestlake University, China

Ex Officio - Kate MacDuffie, MA., PhD
Seattle Children’s Research Institute, USA

Provides oversight of the Society’s scientific publishing activities, including the society journal, Stem Cell Reports, and advises on the editorial calendar of meetings outside the Annual Meeting. This includes concepts for webinar and symposia programming, and review of grassroots proposals. The committee ensures content and programs are complementary, aligned with Society strategic priorities, and in keeping with ISSCR’s standards for excellence and rigor.

Chair - Jianping Fu, PhD
University of Michigan, USA 

Allison Bardin, PhD
Institut Curie, France

Gray Camp, PhDRoche Institute for Translational Bioengineering, Switzerland

Maria Pia Cosma, PhD
Centre for Genomic Regulation, Spain

Fiona Doetsch, PhD
Biozentrum, University of Basel, Switzerland

Karl R. Koehler, PhD
Boston Children's Hospital and Harvard Medical School, USA

Hanna Mikkola, MD, PhD
University of California, Los Angeles, USA

Jing Qu, PhD
Institute of Zoology, Chinese Academy of Sciences (CAS), China

Kaelyn Sumigray, PhD
Yale School of Medicine, USA

Sara Wickström, MD, PhD
Max Planck Institute for Molecular Biomedicine, Germany

Wei Xie, PhD
Tsinghua University, China

Ex Officio - Janet Rossant, CC, PhD, Stem Cell Reports Editor-in-Chiefand The Gairdner Foundation, Toronto, ON, Canada

The Strategic Oversight Committee provides oversight of the structure, mission, and membership with the goal of achieving equity, diversity, and inclusion across all Society functions.

Chair -Megan Munsie, PhD
Murdoch Children’s Research Institute &University of Melbourne, Australia 

Hongkui Deng, PhD
Peking University, China

Fiona Doetsch, PhD
Biozentrum, University of Basel, Switzerland

Arnold R. Kriegstein, MD, PhD
University of California, San Francisco (UCSF), USA

Jane S. Lebkowski, PhD
Regenerative Patch Technologies, USA

Christine L. Mummery, PhD
Leiden University Medical Center, Netherlands

Kathy Niakan, PhD
University of Cambridge, UK

Sally Temple, PhD
Neural Stem Cell Institute, USA

Joanna Wysocka, PhD
Stanford University, USA

Ex Officio - Lorenz Studer, MD 
Memorial Sloan Kettering Cancer Center, USA 

Provides oversight of ISSCR financial planning and activity to ensure future security of the Society, and within that, to fund responsibly activities and programs that ISSCR sees important to its mission, and to assess financial risk.

Chair - Lee Rubin, PhD
Harvard University Department of Stem Cell and Regenerative Biology, USA

Jennifer Brogdon, PhD
Novartis Institute for BioMedical Research, USA

Clive Svendsen, PhD
Cedars-Sinai Regenerative Medicine Institute, USA

Paul J. Tesar, PhD
Case Western Reserve University, USA

Kenneth S. Zaret, PhD
University of Pennsylvania School of Medicine, USA